Prof. Guoliang Shao 邵国良
Chief Physician, Professor
Department of Interventional Radiology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Interventional oncology and tumor imaging. Treats liver, lung, head and neck, gastrointestinal, and gynecologic cancers using chemoembolization, ablation, stenting, and vertebroplasty. Also manages vascular stenosis, thrombosis, and uterine fibroids.
Dr. Shao is a Chief Physician, Professor, and Vice President at Zhejiang Cancer Hospital. Holding a medical doctorate, Dr. Shao specializes in interventional therapy and imaging diagnosis for tumors. Research includes national and provincial projects. Dr. Shao has organized continuing education programs and international conferences.
Professional roles
- Vice Chair, Interventional Oncology Committee, China Anti-Cancer Association
- Standing Committee Member, Minimally Invasive Tumor Therapy Committee, China Anti-Cancer Association
- Standing Committee Member, Tumor Imaging Committee, China Anti-Cancer Association
- Chair, Interventional Medicine Branch, Zhejiang Medical Association
Name order: in Chinese the family name comes first (Shao Guoliang). Papers usually list the name as Guoliang Shao or Shao G.
Selected publications
83 papers on PubMed matched by name and affiliation; 37 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Med, 2026 (senior author): Cadonilimab combined with lenvatinib and transarterial chemoembolization for non-metastatic unresectable hepatocellular carcinoma: a multicenter, open-label, phase 2 study. PubMed 43021311
- Front Immunol, 2024 (senior author): A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy. PubMed 39660131
- Nephrology (Carlton), 2024 (senior author): Deep learning radiomics based on ultrasound images for the assisted diagnosis of chronic kidney disease. PubMed 39134509
- Abdom Radiol (NY), 2024 (senior author): Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma. PubMed 39030402
- Acad Radiol, 2024 (senior author): Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors. PubMed 38052672
- Technol Cancer Res Treat, 2024 (senior author): A Comparative Study of DC Beads, Callispheres and Multimodal Imaging Nano-Assembled Microspheres Loaded with Irinotecan in Vitro. PubMed 39149935
- Drug Deliv, 2023 (senior author): In vitro comparative study of multimodal imaging nano-assembled microspheres with two clinical drug-eluting beads loaded with doxorubicin. PubMed 37078789
- J Mater Chem B, 2023 (senior author): A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells. PubMed 37779509
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion